Pharmacological management of agitation and aggression in an adolescent with autism

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 44, Issue 8, 2005, Pages 829-832

  Kratochvil, Christopher J ^a,f   Findling, Robert L ^b   McDougle, Christopher J ^c   Scahill, Lawrence ^d   Hamarman, Stephanie ^e  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SUNY Downstate Medical Center   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE 2 RECEPTOR; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN 1D RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM;

ADOLESCENT; AGGRESSION; AGITATION; AUTISM; BEHAVIOR DISORDER; CASE REPORT; CHILD PSYCHIATRY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG SAFETY; HUMAN; MALE; MENTAL DEFICIENCY; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; ANXIETY; ARTICLE; DRUG EFFECT;

ADOLESCENT; AGGRESSION; ANXIETY; AUTISTIC DISORDER; HUMANS; MALE;

EID: 22644436925     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000166380.68392.4b     Document Type: Article

References (7)

1. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004), Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27:596-601
2. Findling RL, McNamara NK, Gracious BL et al. (2004), Quetiapine in nine youths with autistic disorder. J Child Adolesc Psychopharmacol 14:287-294
3. Lieberman J (2004), Quetiapine. In: The American Psychiatric Publisher's Textbook of Psychopharmacology, 3rd ed., Schatzberg A, Nemeroff C, eds. Arlington, VA: American Psychiatric Press, pp 473-486
4. Martin A, Koenig K, Scahill L, Bregman J (1999), Open label quetiapine in the treatment of children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 9:99-107
5. McDougle CJ, Posey DJ (2003), Autistic and other pervasive developmental disorders. In: Pediatric Psychopharmacology: Principles and Practice, Martin A, Scahill L, Charney DS, Leckman JF, eds. New York: Oxford University Press, pp 563-579
6. Research Units on Pediatric Psychopharmacology Autism Network (2002), Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314-321
7. Shea S, Turgay A, Carroll A et al. (2004), Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114:e634-e641